These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 8822921)
1. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921 [TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Broudy VC; Lin NL; Kaushansky K Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585 [TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs. Xie X; Chan RJ; Johnson SA; Starr M; McCarthy J; Kapur R; Yoder MC Blood; 2003 Feb; 101(4):1329-35. PubMed ID: 12393382 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways. Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693 [TBL] [Abstract][Full Text] [Related]
8. An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis. Deng B; Banu N; Malloy B; Hass P; Wang JF; Cavacini L; Eaton D; Avraham H Blood; 1998 Sep; 92(6):1981-8. PubMed ID: 9731056 [TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation. Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659 [TBL] [Abstract][Full Text] [Related]
10. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Broudy VC; Lin NL Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160 [TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells. Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244 [TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling. Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431 [TBL] [Abstract][Full Text] [Related]
13. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458 [TBL] [Abstract][Full Text] [Related]
14. Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice. Yan XQ; Lacey DL; Saris C; Mu S; Hill D; Hawley RG; Fletcher FA Exp Hematol; 1999 Sep; 27(9):1409-17. PubMed ID: 10480432 [TBL] [Abstract][Full Text] [Related]
15. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Hodohara K; Fujii N; Yamamoto N; Kaushansky K Blood; 2000 Feb; 95(3):769-75. PubMed ID: 10648384 [TBL] [Abstract][Full Text] [Related]
16. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo. Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229 [TBL] [Abstract][Full Text] [Related]
17. Role of human interleukin-9 as a megakaryocyte potentiator in culture. Fujiki H; Kimura T; Minamiguchi H; Harada S; Wang J; Nakao M; Yokota S; Urata Y; Ueda Y; Yamagishi H; Sonoda Y Exp Hematol; 2002 Dec; 30(12):1373-80. PubMed ID: 12482498 [TBL] [Abstract][Full Text] [Related]
19. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460 [TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]